Profil
Christopher Wick worked as a Regional Director-Sales at Alexion Pharmaceuticals, Inc. from 2018 to 2022.
He also worked as an Executive Director & Head-Sales US Region at RELIEF THERAPEUTICS Holding SA. Mr. Wick completed his undergraduate degree from New Mexico State University.
Ehemalige bekannte Positionen von Christopher Wick
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2022 |
| RELIEF THERAPEUTICS HOLDING SA | Sales & Marketing | - |
Ausbildung von Christopher Wick
| New Mexico State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
